Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer

被引：0
|
作者：
Chun Li
Yicong Zhang
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of General Surgery
[2] Chinese Academy of Sciences,Hefei Institutes of Physical Science
[3] University of Science and Technology of China,undefined
来源：
BMC Medical Genomics | / 16卷
关键词：
Breast cancer; Cuproptosis; LncRNA; Prognosis; Drug sensitivity; Immune Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer
    Fan, Zhi-yuan
    Liu, Wentao
    Yan, Chao
    Zhu, Zheng-lun
    Xu, Wei
    Li, Jian-fang
    Su, Liping
    Li, Chen
    Zhu, Zheng-gang
    Liu, Bingya
    Yan, Min
    TUMOR BIOLOGY, 2016, 37 (10) : 13265 - 13277
  • [42] A novel cuproptosis-related lncRNA prognostic signature in thyroid cancer
    Liu, Lujia
    Xu, Jie
    Sun, Xifeng
    Zheng, Haitao
    BIOMARKERS IN MEDICINE, 2023, 17 (15) : 643 - 654
  • [43] Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
    Xu, Miaorong
    Mu, Jiayi
    Wang, Jiaojiao
    Zhou, Qin
    Wang, Jianwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer
    Li, Ruowen
    Zhao, Mingjian
    Sun, Min
    Miao, Chengxu
    Lu, Jinghui
    PEERJ, 2023, 11
  • [45] Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
    Yao, Hong-Fei
    He, Min
    Zhu, Yu-Heng
    Zhang, Bo
    Chen, Peng-Cheng
    Huo, Yan-Miao
    Zhang, Jun-Feng
    Yang, Chao
    HELIYON, 2024, 10 (01)
  • [46] A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma
    Wang, Shuo
    Bai, Hongyan
    Fei, Sujuan
    Miao, Bei
    BIOCHEMICAL GENETICS, 2024, 62 (03) : 2332 - 2351
  • [47] A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
    Ren, Lei
    Yang, Xu
    Wang, Weifeng
    Lin, Hansen
    Huang, Guankai
    Liu, Zixiong
    Pan, Jincheng
    Mao, Xiaopeng
    FRONTIERS IN GENETICS, 2023, 14
  • [48] Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
    Cong, Tianhao
    Luo, Yingen
    Liu, Yu
    Yang, Chao
    Yang, Hongcai
    Li, Yujie
    Li, Jingui
    Li, Xiao
    FRONTIERS IN GENETICS, 2022, 13
  • [49] Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer
    Li, Jie
    Wang, Weida
    Xia, Peng
    Wan, Linyun
    Zhang, Li
    Yu, Lei
    Wang, Lily
    Chen, Xi
    Xiao, Yun
    Xu, Chaohan
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (09) : 2150 - 2160
  • [50] Construction of a cuproptosis-related lncRNA signature to predict biochemical recurrence of prostate cancer
    Yu, Zhaojun
    Deng, Huanhuan
    Chao, Haichao
    Song, Zhen
    Zeng, Tao
    ONCOLOGY LETTERS, 2024, 28 (05)
12345